An Anvisa GLP-1 registration check confirms a pen's status in Brazil, but it can't confirm your prescription, your dose, or whether the box in your hand is genuine. Here's how to read the results and where to be careful.
If you live in Brazil, or you're visiting for a few months with a GLP-1 pen in your bag, an Anvisa GLP-1 registration check is a sensible first step. Anvisa, the Agência Nacional de Vigilância Sanitária, is Brazil's national health regulator. It approves medicines for sale in the country and publishes the status of each registered product. Here's how to read what you find, and where that information stops protecting you.
Why the Anvisa record is the first thing to check
A registration tells you the product was evaluated for sale in Brazil. It doesn't confirm your prescription, your dose, or whether the pen suits your body. A registered product can still be the wrong product for you, especially if you're switching from a pen you used back home.
Anvisa's public tools are the place to start. The medicine consultation portal lets you search by brand or active ingredient, and the Bulário Eletrônico holds the official leaflet for each product. Both are on the Anvisa consultation site at consultas.anvisa.gov.br. For the search steps in Portuguese, the walkthrough is one of the posts on the OzemNews blog, but the results always come from Anvisa.
Reading the fields on the results page
The results page can look like a wall of Portuguese labels. Start with the brand name and the active ingredient. Semaglutide, tirzepatide, and liraglutide are the molecules that do the work. Ozempic, Wegovy, and Mounjaro are brand names built on them. The same molecule can appear under more than one brand, so a different brand name doesn't automatically mean a different drug.
Next, look at the registration holder, which is the company legally responsible for the product. Compare that name with the company printed on your box. If they don't match, stop and ask your pharmacist before you do anything else.
Then read the status label exactly as the portal writes it. The portal explains what each label means, and the wording can change, so don't guess from an icon or a color. Any status other than valid is a reason to talk to your prescriber before your next dose.
Finally, compare the pharmaceutical form and presentation with your pen. Is it a single pen? What dose strength? How many doses? If the strength printed on your pen doesn't match the entry, raise it with your prescriber. Here's a short checklist to keep the comparison straight:
- Brand name and active ingredient: what the box says, and the molecule behind it
- Registration holder: the responsible company, which should match the packaging
- Status and presentation: the label on the portal, plus dose strength and number of doses
What registration does not guarantee
A registration check has limits. It doesn't verify that a specific box or pen is authentic. Counterfeits can carry real brand names and convincing packaging, so a valid entry tells you about the product category, not the pen in your hand. Compare the lot number and packaging seals with the official information, and buy only from pharmacies with a valid license.
The registry also doesn't cover manipulated, or compounded, preparations made at a pharmacy. These follow separate rules. Before you assume a compounded product matches a registered pen, check Anvisa's current official position on compounded semaglutide and tirzepatide. News coverage on OzemNews can help you track how these topics evolve, but the official Anvisa page is the authority.
Registration also doesn't replace a prescription or the storage conditions your product needs. Read the storage section of the official leaflet in full. Handling mistakes can affect how the medicine works, and the leaflet is the document that spells out the details for your specific product.
Pens from abroad: what expats and travelers should know
If your pen was bought or prescribed abroad, the Anvisa registry may not list it at all, even if the brand is famous at home. A product missing from the Brazilian database doesn't automatically mean it's illegal. It does mean you need to check the rules for personal import, which are separate from domestic sales and can change. Look at Anvisa's current guidance on the consultation site before you travel. I won't quote limits or quantities here, because those conditions belong to the official text, and they may have been updated since this post was written.
Keep the original box, the label, and your prescription together in one bag, and carry only what the rules allow. If a customs officer asks questions, matching packaging and paperwork keeps the conversation short. Plenty of travelers meet this topic in the news first, and OzemNews can help you get oriented, but the official rule is the one that applies at the border. If you're unsure whether a quantity is within the limit, ask your prescriber or pharmacist before you leave.
When the registry says something is wrong
Two results call for action. The first is a status changed to cancelled or suspended. The second is a product that doesn't appear in the registry even though it's sold as a brand-name pen. Either one means it's time to stop guessing and get help.
If you suspect an irregular product, report it through Anvisa's reporting channel, which you can find on the official site, and tell your pharmacist or prescriber what you found. Check the channel's page to see which languages it accepts. If it requires Portuguese, a translation app can help you draft a short summary.
Don't stop or change your dose on your own. Talk to your prescriber first, keep the packaging, and write down the lot number and registry details. Your prescriber can decide whether to pause treatment or switch products, and the packaging gives them something concrete to work with.
Questions to bring to your doctor or pharmacist
A short list keeps the appointment focused, especially when language is a barrier. Bring the product name, the registration number from the box, and any papers you have. Ask which product and registration number were prescribed, whether the pharmacy is licensed, and whether the item is a manufactured pen or a compounded preparation. Ask how to store the pen at home and what to do if the registry status changes.
Bring the Portuguese leaflet too. You can find it in the Bulário Eletrônico, and a translation app can help you read the storage section together. If the staff speaks English, that's great. If not, the leaflet and your written questions will do most of the work.
FAQ
Can I check whether Ozempic is registered in Brazil myself?
Yes. Anvisa's public consultation portal lets you search by brand or active ingredient, and the Bulário Eletrônico provides the official leaflet for each product.
Does a valid registration mean my pen is genuine?
No. A valid registration confirms the product category was approved. It doesn't verify that a specific box or pen is authentic, so check the lot number and packaging too.
Is my semaglutide pen legal in Brazil if I bought it abroad?
That depends on the rules for personal import, which are separate from domestic sales and can change. Check Anvisa's current guidance and talk to your prescriber before you travel or continue treatment.
What should I do if my Mounjaro status shows as suspended?
Don't stop or adjust your dose on your own. Contact your prescriber and pharmacist, keep the packaging, and note the lot number and registry details so they can advise you.
Sources
Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.
Ozempro — Monitor GLP-1
Track your weight and your progress
Log weight, measurements and labs and see your progress in clear charts — because progress you don't measure is invisible progress.
or download the app
